Core Viewpoint - The Ministry of Finance has issued a notification to address the issue of abnormally low bids in government procurement, particularly in the medical equipment sector, aiming to shift the focus from price wars to rational competition and quality-oriented procurement [2][7]. Government Procurement Regulation - The notification emphasizes the inclusion of medical and experimental equipment procurement projects with high consumable usage into key management categories, establishing regulatory red lines across procurement demand, review scope, and contract fulfillment processes [2][7]. - The notification encourages procurement entities to adopt a full lifecycle cost concept, requiring suppliers to quote costs for operation, maintenance, upgrades, and disposal in procurement documents [7][9]. Abnormal Low Bidding Issues - Abnormal low bidding has disrupted fair competition, with examples such as a procurement project budgeted at 3 million yuan being won for only 1,000 yuan [6]. - The root cause of low bidding is identified as a profit bundling model, where companies use low prices to secure hospital channels and later profit from consumables and maintenance services [6][12]. New Regulatory Measures - The notification defines four triggering conditions for abnormal low bids, including bids below 50% of the average passing bid and below 45% of the maximum project price [8]. - It mandates that procurement review committees must initiate an examination process for bids that meet these conditions, requiring suppliers to justify their pricing with detailed cost breakdowns [8][9]. Industry Transformation - The new regulations are expected to accelerate industry reshuffling, concentrating market share among leading companies with core technologies and compliance capabilities [12][13]. - The separation of equipment and consumable procurement is becoming a trend, breaking previous profit bundling chains and allowing leading companies to leverage their comprehensive service capabilities [13]. Market Outlook - The medical equipment market is projected to grow, with a 25% increase in investment by 2027 compared to 2023, driven by the new regulations that aim to purify the competitive environment [12]. - Companies that can provide innovative products with real clinical value and full lifecycle services are expected to gain a competitive edge, moving away from a purely price-based strategy [12][13].